Susanne Ammon-Treiber

Susanne Ammon-Treiber, PD Dr. med., serves as a scientific staff member at the Pharmaceutical Institute of the University of Tübingen within the Faculty of Science, specifically in the Department of Pharmacology, Toxicology and Clinical Pharmacy. Holding dual professional qualifications as both a licensed pharmacist (Apothekerin) and physician (Ärztin) with specialization in Clinical Pharmacology, her work uniquely bridges pharmaceutical sciences and clinical medicine with focus on drug mechanisms, pharmacokinetics, and therapeutic applications.

Dr. Ammon-Treiber's academic foundation includes:

• Pharmacy studies (1983-1988) at University of Tübingen, obtaining Apothekerin licensure in 1988
• Human medicine studies (1989-1996) at University of Tübingen
• Medical doctorate (Dr. med.) from University of Tübingen in 1996
• Physician licensure (Approbation) in 1998
• Habilitation in Pharmacology at Otto-von-Guericke-Universität Magdeburg (2006)
• Rehabilitation (Umhabilitation) at Medical Faculty of University of Tübingen (2010) with teaching authorization in Experimental and Clinical Pharmacology

Her research program demonstrates sophisticated integration of molecular neuroscience with pharmaceutical applications. Early career work established her expertise in opioid receptor pharmacology, particularly investigating morphine's effects on gene expression, heat shock protein responses, and neuronal adaptation using transgenic mouse models. This foundational neuropharmacological research has evolved toward more applied pharmaceutical technologies, with recent publications focusing on nanoparticle delivery systems for pulmonary administration and cancer therapy. Her work on antisense RNA nanoplexes for lung cancer treatment represents a significant translational advancement from basic mechanism studies to therapeutic applications.

Analysis of her publication trajectory from 2002-2012 reveals a strategic progression from fundamental neuropharmacology toward pharmaceutical technology development. While maintaining her expertise in opioid mechanisms and gene expression, she has successfully expanded into drug delivery systems, demonstrating remarkable interdisciplinary versatility. Her research consistently addresses clinically relevant questions while maintaining strong mechanistic foundations.

Dr. Ammon-Treiber maintains active membership in professional organizations including the German Society for Pharmaceutical Medicine (DGPharMed) and the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT), reflecting her dual commitment to both pharmaceutical sciences and clinical practice.